MFN2 and lipodystrophy: This may be an indication that impaired oxidative phosphorylation (OxPhos) is not the mechanism mediating MFN2-related lipodystrophy, even though impaired OxPhos is seen in vivo (evidenced by increased serum lactate, and transcriptomic signatures in affected tissue (Rocha 2017).